Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
STABLE HYBRID FC FUSION G-CSF FORMULATION
Document Type and Number:
WIPO Patent Application WO/2019/212429
Kind Code:
A3
Abstract:
The present invention comprises a stable form of hybrid Fc fused Granulocyte Colony Stimulating Factor (G-CSF)formulation comprising (i) a therapeutically effective amount of hybrid Fc fusion G-CSF, (ii) a buffer system, (iii) at least one stabilizerand (iv) at least one surfactant, and (v) optionally propylene glycol as organic solvent, suitable for administration via a subcutaneous (SC) route.

Inventors:
ÖNCEL HATICE (TR)
ÇAPAN YILMAZ (TR)
DAĞLIKOCA DUYGU (TR)
ERDOĞAN DAĞDAŞ HURIYE (TR)
ŞAHİN ADEM (TR)
ÇORBACIOĞLU MELTEM (TR)
ÖZKAN AYLIN (TR)
SARRAÇOĞLU NAGEHAN (TR)
Application Number:
PCT/TR2018/050208
Publication Date:
March 12, 2020
Filing Date:
May 04, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ILKOGEN ILAC SANAYI VE TICARET A S (TR)
International Classes:
A61K9/00; A61K9/08; A61K38/19; A61K47/02; A61K47/10
Domestic Patent References:
WO2012165917A12012-12-06
Foreign References:
US20030082679A12003-05-01
US20160362473A12016-12-15
US8586048B22013-11-19
Attorney, Agent or Firm:
BULUT, Pınar (TR)
Download PDF: